| PH8 | Name: | 5-phenyl-L-norvaline | Formula: | C11 H15 N O2 | SMILES: | C(O)(=O)C(N)CCCc1ccccc1 | InChi: | InChI=1S/C11H15NO2/c12-10(11(13)14)8-4-7-9-5-2-1-3-6-9/h1-3,5-6,10H,4,7-8,12H2,(H,13,14)/t10-/m0/s1 | Definition date: | 2015-03-10 | Last modified: | 2023-11-03 | Release date: | 2015-04-15 | Identifier: | 5-phenyl-L-norvaline |
|
| TY8 | Name: | 2,4-bis(hydroperoxy)-5-hydroxy-L-phenylalanine | Formula: | C9 H11 N O7 | SMILES: | O=C(O)C(N)Cc1c(OO)cc(OO)c(O)c1 | InChi: | InChI=1S/C9H11NO7/c10-5(9(12)13)1-4-2-6(11)8(17-15)3-7(4)16-14/h2-3,5,11,14-15H,1,10H2,(H,12,13)/t5-/m0/s1 | Definition date: | 2010-07-19 | Last modified: | 2023-11-03 | Identifier: | 2,4-bis(hydroperoxy)-5-hydroxy-L-phenylalanine |
|
| 5MW | Name: | (2~{S})-5-[4-(aminomethyl)-1,2,3-triazol-1-yl]-2-azanyl-pentanoic acid | Formula: | C8 H15 N5 O2 | SMILES: | NCc1cn(CCC[CH](N)C(O)=O)nn1 | InChi: | InChI=1S/C8H15N5O2/c9-4-6-5-13(12-11-6)3-1-2-7(10)8(14)15/h5,7H,1-4,9-10H2,(H,14,15)/t7-/m0/s1 | Definition date: | 2015-10-23 | Last modified: | 2023-11-03 | Release date: | 2016-05-18 | Identifier: | (2~{S})-5-[4-(aminomethyl)-1,2,3-triazol-1-yl]-2-azanyl-pentanoic acid |
|
| NEL | Name: | 2-(3-chlorophenyl)-N-(1H-indazol-4-yl)acetamide | Formula: | C15 H12 Cl N3 O | SMILES: | Clc1cccc(c1)CC(=O)Nc1cccc2[NH]ncc12 | InChi: | InChI=1S/C15H12ClN3O/c16-11-4-1-3-10(7-11)8-15(20)18-13-5-2-6-14-12(13)9-17-19-14/h1-7,9H,8H2,(H,17,19)(H,18,20) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(1H-indazol-4-yl)acetamide |
|
| RW0 | Name: | (3R,4S)-6-chloro-N-[7-(methanesulfonyl)isoquinolin-4-yl]-3-methyl-2-[2-(methylamino)-2-oxoethyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide | Formula: | C24 H23 Cl N4 O5 S | SMILES: | CS(=O)(=O)c1ccc2c(c1)cncc2NC(=O)C1c2cc(Cl)ccc2C(=O)N(CC(=O)NC)C1C | InChi: | InChI=1S/C24H23ClN4O5S/c1-13-22(19-9-15(25)4-6-18(19)24(32)29(13)12-21(30)26-2)23(31)28-20-11-27-10-14-8-16(35(3,33)34)5-7-17(14)20/h4-11,13,22H,12H2,1-3H3,(H,26,30)(H,28,31)/t13-,22-/m1/s1 | Definition date: | 2023-08-22 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (3R,4S)-6-chloro-N-[7-(methanesulfonyl)isoquinolin-4-yl]-3-methyl-2-[2-(methylamino)-2-oxoethyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide |
|
| VLT | Name: | (2E,4S)-4-amino-5-(4-hydroxyphenyl)pent-2-enoic acid | Formula: | C11 H13 N O3 | SMILES: | O=C(O)C=CC(N)Cc1ccc(O)cc1 | InChi: | InChI=1S/C11H13NO3/c12-9(3-6-11(14)15)7-8-1-4-10(13)5-2-8/h1-6,9,13H,7,12H2,(H,14,15)/b6-3+/t9-/m1/s1 | Definition date: | 2010-09-24 | Last modified: | 2023-11-03 | Identifier: | (2E,4S)-4-amino-5-(4-hydroxyphenyl)pent-2-enoic acid |
|
| NEP | Name: | N1-PHOSPHONOHISTIDINE | Formula: | C6 H10 N3 O5 P | SMILES: | O=P(O)(O)n1cc(nc1)CC(C(=O)O)N | InChi: | InChI=1S/C6H10N3O5P/c7-5(6(10)11)1-4-2-9(3-8-4)15(12,13)14/h2-3,5H,1,7H2,(H,10,11)(H2,12,13,14)/t5-/m0/s1 | Definition date: | 1999-07-26 | Last modified: | 2023-11-03 | Identifier: | 1-phosphono-L-histidine |
|
| O8L | Name: | (2S)-2-(3-chloro-5-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)-N-(4-methylpyridin-3-yl)propanamide | Formula: | C18 H18 Cl N3 O3 | SMILES: | Cc1ccncc1NC(=O)C(C)c1cc(Cl)cc(OC2CC(=O)N2)c1 | InChi: | InChI=1S/C18H18ClN3O3/c1-10-3-4-20-9-15(10)21-18(24)11(2)12-5-13(19)7-14(6-12)25-17-8-16(23)22-17/h3-7,9,11,17H,8H2,1-2H3,(H,21,24)(H,22,23)/t11-,17+/m0/s1 | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (2S)-2-(3-chloro-5-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)-N-(4-methylpyridin-3-yl)propanamide |
|
| TYI | Name: | 3,5-DIIODOTYROSINE | Formula: | C9 H9 I2 N O3 | SMILES: | Ic1cc(cc(I)c1O)CC(C(=O)O)N | InChi: | InChI=1S/C9H9I2NO3/c10-5-1-4(2-6(11)8(5)13)3-7(12)9(14)15/h1-2,7,13H,3,12H2,(H,14,15)/t7-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | 3,5-diiodo-L-tyrosine |
|
| TYJ | Name: | 2,5-dihydroxy-N-methyl-L-tyrosine | Formula: | C10 H13 N O5 | SMILES: | O=C(O)C(NC)Cc1c(O)cc(O)c(O)c1 | InChi: | InChI=1S/C10H13NO5/c1-11-6(10(15)16)2-5-3-8(13)9(14)4-7(5)12/h3-4,6,11-14H,2H2,1H3,(H,15,16)/t6-/m0/s1 | Definition date: | 2011-02-09 | Last modified: | 2023-11-03 | Identifier: | 2,5-dihydroxy-N-methyl-L-tyrosine |
|
| P2Q | Name: | 2-hydroxy-5-{[(1S,2E)-1-formyl-4-phenoxybut-2-en-1yl]amino}-L-tyrosine | Formula: | C20 H22 N2 O6 | SMILES: | N[CH](Cc1cc(N[CH](C=O)C=CCOc2ccccc2)c(O)cc1O)C(O)=O | InChi: | InChI=1S/C20H22N2O6/c21-16(20(26)27)9-13-10-17(19(25)11-18(13)24)22-14(12-23)5-4-8-28-15-6-2-1-3-7-15/h1-7,10-12,14,16,22,24-25H,8-9,21H2,(H,26,27)/b5-4+/t14-,16-/m0/s1 | Synonyms: | 3-{[(1S,2E)-1-formyl-4-phenoxybut-2-en-1-yl]amino}-6-hydroxy-L-tyrosine | Definition date: | 2009-11-10 | Last modified: | 2023-11-03 | Identifier: | (2S)-2-azanyl-3-[2,4-dihydroxy-5-[[(E,2S)-1-oxo-5-phenoxy-pent-3-en-2-yl]amino]phenyl]propanoic acid |
|
| RW9 | Name: | 2-[(3'S)-6-chloro-1'-(isoquinolin-4-yl)-1,2'-dioxo-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2(3H)-yl]-N-methylacetamide | Formula: | C24 H21 Cl N4 O3 | SMILES: | CNC(=O)CN1CC2(CCN(C2=O)c2cncc3ccccc32)c2cc(Cl)ccc2C1=O | InChi: | InChI=1S/C24H21ClN4O3/c1-26-21(30)13-28-14-24(19-10-16(25)6-7-18(19)22(28)31)8-9-29(23(24)32)20-12-27-11-15-4-2-3-5-17(15)20/h2-7,10-12H,8-9,13-14H2,1H3,(H,26,30)/t24-/m1/s1 | Definition date: | 2023-08-22 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-[(3'S)-6-chloro-1'-(isoquinolin-4-yl)-1,2'-dioxo-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2(3H)-yl]-N-methylacetamide |
|
| XXY | Name: | 2-[(1R,2R)-1-amino-2-hydroxypropyl]-1-(carboxymethyl)-4-(1H-imidazol-5-ylmethyl)-1H-imidazol-5-olate | Formula: | C12 H16 N5 O4 | SMILES: | [O-]c1c(nc(n1CC(=O)O)C(N)C(O)C)Cc2cncn2 | InChi: | InChI=1S/C12H17N5O4/c1-6(18)10(13)11-16-8(2-7-3-14-5-15-7)12(21)17(11)4-9(19)20/h3,5-6,10,18,21H,2,4,13H2,1H3,(H,14,15)(H,19,20)/p-1/t6-,10+/m1/s1 | Synonyms: | CHROMOPHORE THR-HIS-GLY | Definition date: | 2006-02-10 | Last modified: | 2023-11-03 | Identifier: | 2-[(1R,2R)-1-amino-2-hydroxypropyl]-1-(carboxymethyl)-4-(1H-imidazol-5-ylmethyl)-1H-imidazol-5-olate |
|
| 01B | Name: | (2S,3R)-3-amino-2-hydroxy-4-phenylbutanoic acid | Formula: | C10 H13 N O3 | SMILES: | O=C(O)C(O)C(N)Cc1ccccc1 | InChi: | InChI=1S/C10H13NO3/c11-8(9(12)10(13)14)6-7-4-2-1-3-5-7/h1-5,8-9,12H,6,11H2,(H,13,14)/t8-,9+/m1/s1 | Definition date: | 2010-06-18 | Last modified: | 2023-11-03 | Identifier: | (2S,3R)-3-amino-2-hydroxy-4-phenylbutanoic acid |
|
| TYO | Name: | (4Z,6E)-2-AMINO-7-HYDROPEROXY-4-[(E)-2-HYDROXYVINYL]HEPTA-4,6-DIENOIC ACID | Formula: | C9 H13 N O5 | SMILES: | O=C(O)C(N)CC(C=CO)=CC=COO | InChi: | InChI=1S/C9H13NO5/c10-8(9(12)13)6-7(3-4-11)2-1-5-15-14/h1-5,8,11,14H,6,10H2,(H,12,13)/b4-3?,5-1+,7-2+/t8-/m0/s1 | Definition date: | 2006-09-22 | Last modified: | 2023-11-03 | Identifier: | (2S,4Z,6E)-2-amino-7-hydroperoxy-4-[(E)-2-hydroxyethenyl]hepta-4,6-dienoic acid |
|
| XY1 | Name: | 4-[(E)-[5-(2-azanylethyl)-2-oxidanyl-phenyl]diazenyl]benzoic acid | Formula: | C15 H15 N3 O3 | SMILES: | O=C(O)c2ccc(/N=N/c1cc(ccc1O)CCN)cc2 | InChi: | InChI=1S/C15H15N3O3/c16-8-7-10-1-6-14(19)13(9-10)18-17-12-4-2-11(3-5-12)15(20)21/h1-6,9,19H,7-8,16H2,(H,20,21)/b18-17+ | Synonyms: | 4-[5-(2-Aminoethyl)-2-hydroxyphenylazo]-benzoic acid | Definition date: | 2013-03-12 | Last modified: | 2023-11-03 | Release date: | 2014-03-26 | Identifier: | 4-{(E)-[5-(2-aminoethyl)-2-hydroxyphenyl]diazenyl}benzoic acid |
|
| TYQ | Name: | 3-AMINO-6-HYDROXY-TYROSINE | Formula: | C9 H12 N2 O4 | SMILES: | O=C(O)C(N)Cc1c(O)cc(O)c(N)c1 | InChi: | InChI=1S/C9H12N2O4/c10-5-1-4(2-6(11)9(14)15)7(12)3-8(5)13/h1,3,6,12-13H,2,10-11H2,(H,14,15)/t6-/m0/s1 | Definition date: | 1999-08-26 | Last modified: | 2023-11-03 | Identifier: | 3-amino-6-hydroxy-L-tyrosine |
|
| TYS | Name: | O-SULFO-L-TYROSINE | Formula: | C9 H11 N O6 S | SMILES: | O=C(O)C(N)Cc1ccc(OS(=O)(=O)O)cc1 | InChi: | InChI=1S/C9H11NO6S/c10-8(9(11)12)5-6-1-3-7(4-2-6)16-17(13,14)15/h1-4,8H,5,10H2,(H,11,12)(H,13,14,15)/t8-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | O-sulfo-L-tyrosine |
|
| TYT | Name: | TYROSINE DERIVATIVE | Formula: | C18 H20 N2 O4 | SMILES: | O=C(O)C(N)CC3C(=O)C=C(O)/C(=N/C2CC2c1ccccc1)C3 | InChi: | InChI=1S/C18H20N2O4/c19-13(18(23)24)6-11-7-15(17(22)9-16(11)21)20-14-8-12(14)10-4-2-1-3-5-10/h1-5,9,11-14,22H,6-8,19H2,(H,23,24)/b20-15+ | Synonyms: | 2-AMINO-3-[4-HYDROXY-6-OXO-3-(2-PHENYL-CYCLOPROPYLIMINO)-CYCLOHEXA-1,4-DIENYL]-PROPIONIC ACID | Definition date: | 2002-06-21 | Last modified: | 2023-11-03 | Identifier: | 3-{(5E)-4-hydroxy-2-oxo-5-[(2-phenylcyclopropyl)imino]cyclohex-3-en-1-yl}alanine |
|
| VM9 | Name: | (6M)-6-(6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-2-{[(2R,4R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}quinazolin-7-yl)-4-methyl-5-(trifluoromethyl)pyridin-2-amine | Formula: | C29 H31 Cl F5 N7 O | SMILES: | FC1CC2(CCCN2C1)COc1nc2c(F)c(c3nc(N)cc(C)c3C(F)(F)F)c(Cl)cc2c(n1)N1CC2CCC(N2)C1 | InChi: | InChI=1S/C29H31ClF5N7O/c1-14-7-20(36)38-25(22(14)29(33,34)35)21-19(30)8-18-24(23(21)32)39-27(40-26(18)41-11-16-3-4-17(12-41)37-16)43-13-28-5-2-6-42(28)10-15(31)9-28/h7-8,15-17,37H,2-6,9-13H2,1H3,(H2,36,38)/t15-,16-,17+,28+/m1/s1 | Definition date: | 2023-09-13 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (6M)-6-(6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-2-{[(2R,4R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}quinazolin-7-yl)-4-methyl-5-(trifluoromethyl)pyridin-2-amine |
|
| TYY | Name: | 3-(4-HYDROXY-3-IMINO-6-OXO-CYCLOHEXA-1,4-DIENYL)-ALANINE | Formula: | C9 H10 N2 O4 | SMILES: | O=C1C=C(O)C(=[N@H])C=C1CC(C(=O)O)N | InChi: | InChI=1S/C9H10N2O4/c10-5-1-4(2-6(11)9(14)15)7(12)3-8(5)13/h1,3,6,10,13H,2,11H2,(H,14,15)/b10-5-/t6-/m0/s1 | Definition date: | 1999-08-26 | Last modified: | 2023-11-03 | Identifier: | 3-[(3Z)-4-hydroxy-3-imino-6-oxocyclohexa-1,4-dien-1-yl]-L-alanine |
|
| RWO | Name: | (4R)-6-chloro-4-methyl-1,1-dioxo-N-(5,6,7,8-tetrahydroisoquinolin-4-yl)-1,2,3,4-tetrahydro-1lambda~6~,2-benzothiazine-4-carboxamide | Formula: | C19 H20 Cl N3 O3 S | SMILES: | Clc1ccc2c(c1)C(C)(CNS2(=O)=O)C(=O)Nc1cncc2CCCCc21 | InChi: | InChI=1S/C19H20ClN3O3S/c1-19(11-22-27(25,26)17-7-6-13(20)8-15(17)19)18(24)23-16-10-21-9-12-4-2-3-5-14(12)16/h6-10,22H,2-5,11H2,1H3,(H,23,24)/t19-/m0/s1 | Definition date: | 2023-08-22 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (4R)-6-chloro-4-methyl-1,1-dioxo-N-(5,6,7,8-tetrahydroisoquinolin-4-yl)-1,2,3,4-tetrahydro-1lambda~6~,2-benzothiazine-4-carboxamide |
|
| TKL | Name: | (2S)-2-{4-[(1S)-1,5-diaminopentyl]-1H-1,2,3-triazol-1-yl}-4-methylpentanoic acid | Formula: | C13 H25 N5 O2 | SMILES: | O=C(C(n1cc(nn1)C(CCCCN)N)CC(C)C)O | InChi: | InChI=1S/C13H25N5O2/c1-9(2)7-12(13(19)20)18-8-11(16-17-18)10(15)5-3-4-6-14/h8-10,12H,3-7,14-15H2,1-2H3,(H,19,20)/t10-,12-/m0/s1 | Definition date: | 2005-07-29 | Last modified: | 2023-11-03 | Identifier: | (2S)-2-{4-[(1S)-1,5-diaminopentyl]-1H-1,2,3-triazol-1-yl}-4-methylpentanoic acid |
|
| XYG | Name: | [(4Z)-2-[(1Z)-ETHANIMIDOYL]-4-(4-HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | Formula: | C14 H13 N3 O4 | SMILES: | O=C1C(N=C(C(=[N@H])C)N1CC(=O)O)=Cc2ccc(O)cc2 | InChi: | InChI=1S/C14H13N3O4/c1-8(15)13-16-11(14(21)17(13)7-12(19)20)6-9-2-4-10(18)5-3-9/h2-6,15,18H,7H2,1H3,(H,19,20)/b11-6-,15-8+ | Synonyms: | CHROMOPHORE (DECARBOXYLATED ASP-TYR-GLY) | Definition date: | 2006-11-16 | Last modified: | 2023-11-03 | Identifier: | {(4Z)-2-[(1E)-ethanimidoyl]-4-[(4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| RWT | Name: | (4S)-6-chloro-4-methyl-1,1-dioxo-N-(5,6,7,8-tetrahydroisoquinolin-4-yl)-1,2,3,4-tetrahydro-1lambda~6~,2-benzothiazine-4-carboxamide | Formula: | C19 H20 Cl N3 O3 S | SMILES: | Clc1ccc2c(c1)C(C)(CNS2(=O)=O)C(=O)Nc1cncc2CCCCc21 | InChi: | InChI=1S/C19H20ClN3O3S/c1-19(11-22-27(25,26)17-7-6-13(20)8-15(17)19)18(24)23-16-10-21-9-12-4-2-3-5-14(12)16/h6-10,22H,2-5,11H2,1H3,(H,23,24)/t19-/m1/s1 | Definition date: | 2023-08-22 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (4S)-6-chloro-4-methyl-1,1-dioxo-N-(5,6,7,8-tetrahydroisoquinolin-4-yl)-1,2,3,4-tetrahydro-1lambda~6~,2-benzothiazine-4-carboxamide |
|